Recruiting NCT06581718
Eye Gaze Technology for Endoscopic Inspection of the Gastrointestinal Tract
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Eye Gaze Control.
- Who it may be relevant to
- Registry conditions: Cancer Gi. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Robotic controlled endoscopy of GI tract.
Detailed description
A robotised conventional endoscope will be used to examine the GI tract of 10 patients following successful benchtop trials.
Interventions
- Device Eye Gaze Control
Eye Gaze Control - UGI and LGI endoscopy
Primary outcome measures
- Time of completion [Time frame: 6 months]
- User Experience survey [Time frame: 6 months]
- Patient Experience survey [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Routine UGI endoscopic indications
Exclusion criteria
- Varices
- <18
- GI haemorrhage
- PS > 2
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Device feasibility
Study locations
United Kingdom · 1 center
- Imperial College London — London
Identifiers
NCT: NCT06581718 · 20SM6304